Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of anisomycin to preparation of medicine for preventing/treating ovarian cancer

A technology for anisomycin and ovarian cancer, applied in the direction of drug combinations, antineoplastic drugs, active ingredients of heterocyclic compounds, etc., can solve the problems of expression up-regulation and achieve great social benefits and good clinical application prospects

Active Publication Date: 2017-02-22
SHANGHAI GERIATRIC INST OF CHINESE MEDICINE
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Guo et al. reported that after the intervention of anisomycin, the level of methyltransferase in SH-SY5Y cells decreased, and the promoters of three genes were demethylated, which led to the upregulation of the expression of APP, PS1 and BACE1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of anisomycin to preparation of medicine for preventing/treating ovarian cancer
  • Application of anisomycin to preparation of medicine for preventing/treating ovarian cancer
  • Application of anisomycin to preparation of medicine for preventing/treating ovarian cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 Isolation of tumor stem cells from ovarian cancer patients

[0023] Undifferentiated mixed epithelial ovarian cancer in 7 patients with ovarian cancer. The age, stage, degree of differentiation, and histological distribution of all ovarian cancer patient populations are shown in surface 1 .

[0024] Isolation of tumor stem cells from ovarian cancer patients (7 ovarian cancer patients underwent surgical resection of ovarian cancer tissue. In this experiment, the surgically removed tissue was collected in a sterile centrifuge tube, digested with 0.25% trypsin to form a single cell suspension, each 100 μL 4 μL of CD44 and CD117 monoclonal antibodies (mouse anti-human CD117-FITC; rabbit anti-human CD44-PE, eBioscience) were added to the ovarian cancer cell suspension, and the cells were incubated at 4°C for 30 minutes. After washing once with salt-buffered saline (PBS), the CD44+ / CD117+ OCSCs cell subsets were isolated by flow cytometry (BD FACS Aria, BD Biosc...

Embodiment 2

[0028] Example 2 Anisomycin significantly inhibits the proliferation and invasion of OCSCs

[0029] Detection of cell proliferation by MTT method (thiazolan method)

[0030] Cells were seeded on (2 × 10 3 / ml) 96-well plate and incubate at 37°C, 5% CO 2 The cells were cultured in DMEM (modified high glucose cell culture medium) medium containing 10% FBS (fetal bovine serum) under conditions until 85% of the cells were confluent. MTT (3(V / V)-diphenyl bromide; Sigma) reagent (5 mg / ml) was added to the cell culture medium at various time points and incubated at 37°C for 4 hours. The reaction was stopped by the addition of 150 μL of dimethyl sulfoxide (DMSO, Sigma Chemicals) per well. Cells were lysed for 15 min, and the 96-well plate was gently shaken for 5 min. The absorbance value was measured by enzyme-linked immunosorbent assay (ELISA) at 490 nm (model 680, Bio-Rad Bio-Rad).

[0031] Annexin V-FITC / PI (cell membrane phosphatidylserine-fluorescein isothiocyanate / propidium...

Embodiment 3

[0038] Example 3 Anisomycin stimulates the expression of apoptosis-related protein and lncRNA BACE1-AS (long non-coding ribonucleic acid β-degrading enzyme translation nucleic acid sequence) in OCSCs

[0039] RNA extraction and analysis by qRT-PCR (real-time quantitative polymerase chain reaction)

[0040] Total RNA was isolated from each cell using Trizol (cell / tissue total RNA extraction buffer) reagent. RNA samples were treated with Dnase I (Sigma-Aldrich) (type I deoxyribonuclease (Sigma Reagent Co., Ltd.)), and revertraα (α-type ribonucleic acid reverse transcription) first-strand cDNA synthesis enzyme kit (TOYOBO) was used Quantify and reverse transcribed into cDNA. Real-time fluorescence quantitative RT-PCR adopts realplex4 (fluorescence 4-color channel) real-time fluorescence quantitative RT-PCR detection system of Eppendorf (Germany), and SYBR green fluorescence quantitative PCR Master Mix (Toyobo) is used as detection dye. Amplification was performed for 40 cycles ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of anisomycin to preparation of a medicine for preventing / treating ovarian cancer. The application is characterized in that the structural formula of the anisomycin is as follow: (the formula is as shown in the description); and the medicine is a medicinal composition consisting of the anisomycin serving as the active component, and medicinal auxiliary materials. The medicinal composition is an oral preparation or injection. The result of an experiment about the influence of the anisomycin on OCSCs (ovarian cancer stem cells) indicates that the anisomycin can obviously inhibit OCSCs proliferation and invasion. An experiment of stimulating OCSCs apoptosis related protein lncRNA BACE1-AS expression by the anisomycin is conducted, and data indicates that the anisomycin can induce high expression of starch-like-beta related protein of lncRNA BACE1-AS. Therefore, the anisomycin can be used for preparing the medicine for preventing / treating ovarian cancer. According to the application, a new medicine for preventing / treating ovarian cancer is provided, a good clinical application prospect is achieved and huge social benefits are achieved.

Description

technical field [0001] The present invention relates to medicine, in particular to Anisomycin in the preparation of prophylaxis / Application of drugs in the treatment of ovarian cancer . Background technique [0002] At present, human ovarian cancer stem cells have been found to be the main reason for the resistance of ovarian cancer cells to chemotherapeutic drugs and the susceptibility to metastasis, recurrence and poor prognosis of ovarian cancer. However, the underlying mechanism of the proliferation and erosion of OCSCs (ovarian cancer stem cells) is still unclear, and there is no effective medical means to inhibit it. Fan et al. reported that overexpression of microRNA-20a can promote the proliferation and invasion of ovarian cancer cells by inhibiting the expression of amyloid precursor protein (Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, Liu M, Li X and Tang H. miR-20a promotes proliferation and invASion by targeting APP in human ovarian cancer cells. Acta Biochi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/40A61P35/00
Inventor 刘特陈川郁志华王素魏黄永毅
Owner SHANGHAI GERIATRIC INST OF CHINESE MEDICINE